Spectral Diagnostics EBITDA Margin 2010-2025 | EDTXF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Spectral Diagnostics ebitda margin from 2010 to 2025. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Spectral Diagnostics EBITDA Margin 2010-2025 | EDTXF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Spectral Diagnostics ebitda margin from 2010 to 2025. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$183.2B
Intuitive Surgical (ISRG)	$171B
IDEXX Laboratories (IDXX)	$52.3B
Edwards Lifesciences (EW)	$45.9B
Alcon (ALC)	$42.8B
IQVIA Holdings (IQV)	$32.2B
DexCom (DXCM)	$31.4B
Mettler-Toledo (MTD)	$27.1B
STERIS (STE)	$24.2B
Waters (WAT)	$17.5B
SONOVA HOLDING (SONVY)	$16.7B
Hologic (HOLX)	$15.1B
Penumbra (PEN)	$9.9B
Sysmex ADR (SSMXY)	$8.4B
Masimo (MASI)	$8.3B
Globus Medical (GMED)	$8.1B
Teleflex (TFX)	$5.4B
Glaukos (GKOS)	$5.2B
TransMedics (TMDX)	$4.4B
Integer Holdings (ITGR)	$3.7B
LivaNova (LIVN)	$3B
Veracyte (VCYT)	$2.4B
Alphatec Holdings (ATEC)	$2.3B
PROCEPT BioRobotics (PRCT)	$2.2B
Nihon Kohden (NHNKY)	$2B
Artivion (AORT)	$2B
Elekta AB (EKTAY)	$1.9B
Pulse Biosciences (PLSE)	$1.2B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B